Total Funding
18
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3460102
Angiologix offers cardiovascular diagnostic products used for accurate, non-invasive, and point-of-care testing of endothelial dysfunction.
Acquired by 
Everist Genomics
Bill Worzel: Secretary
About the Company
As of October 31, 2011, Angiologix, Inc. was acquired by Everist Genomics. Angiologix, Inc., a medical diagnostic device company, provides cardiovascular diagnostic products. Its products are used as tools for accurate, non-invasive, and point-of-care testing of endothelial dysfunction. The company’s diagnostic products are also used in
physicians' practices for diagnosing cardiovascular diseases, and for monitoring the effectiveness of cardiovascular therapies. It serves physician-specialists, cardiologists, vascular medicine specialists, endocrinologists, and primary care physicians. Angiologix, Inc. was founded in 2007 and is based in Mountain View, California.
